Food, drugs, devices › Bethel Nutritional Consulting, Inc
Drug recall: SLIM-K, 30 Capsules, barcode 160126417509, Distributed by: Bethel Inc.
FDA enforcement event 70089 is a drug recall by Bethel Nutritional Consulting, Inc of New York, NY, initiated 19 Dec 2014 and classified Class I, with 1 product record.
FDA defines Class I as a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. 15% of the 313 drug enforcement events initiated in 2014 carry the same class.
Status: Terminated, terminated 27 Jun 2018. Initiation: voluntary: firm initiated. Bethel Nutritional Consulting, Inc has 4 enforcement events on this register, with a median of 1 product record per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Bethel Nutritional Consulting, Inc, New York, NY.
Reason for recall
"Marketed Without An Approved NDA/ANDA: Product was found to contain sibutramine, desmethylsibutramine and phenolphthalein based on FDA sampling and analysis."
Distribution
"Nationwide"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| D-1207-2015 | SLIM-K, 30 Capsules, barcode 160126417509, Distributed by: Bethel Inc. | UNKNOWN | Class I | Terminated | 15 Jul 2015 |
Context
Other enforcement events for Bethel Nutritional Consulting, Inc
| Initiated | Product (first record) | Type | Class | Records |
|---|---|---|---|---|
| 19 Dec 2014 | B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Stree | Drug | Class II | 1 |
| 5 Aug 2013 | Quick Thin (citrus aurantium extract, sweet potato fiber, cyamopsis gum powder, alfalfa, mulberry leaf, guarana, spiruli | Drug | Class I | 2 |
| 11 Jun 2013 | Bethel 30 capsules, packaged in 30 count bottles, Distributed by BETHEL INC. New York, New York | Drug | Class I | 1 |
All 4 events for Bethel Nutritional Consulting, Inc
Questions and answers
Why was this drug recalled?
FDA's record gives the reason for recall as: "Marketed Without An Approved NDA/ANDA: Product was found to contain sibutramine, desmethylsibutramine and phenolphthalein based on FDA sampling and analysis."
What does Class I mean?
FDA classifies recalls by relative degree of health hazard. Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
Where was the product distributed?
FDA's distribution pattern field reads: "Nationwide"
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 27 Jun 2018. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.